4VI.F Stock Analysis
4V
Uncovered
Genomtec SA is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Genomtec SA engages in the research and development of molecular diagnostic equipment. The company is headquartered in Wroclaw, Woj. Dolnoslaskie. The company went IPO on 2021-03-17. The firm is focused on development of of Genomtec ID, a mobile platform for genetic diagnosis in the point of patient care. Its creation and commercialization allows the diagnostic process to be executed in point of care setting, such as: primary care clinics, pharmacies, doctor’s offices, hospital emergency departments (ERs) without the need for complicated and time-consuming laboratory workflow conducted by qualified personnel.